跳至主要内容
临床试验/JPRN-UMIN000037556
JPRN-UMIN000037556尚未招募未知

Investigation of the effects of 8-week continuous ingestion of plant tuber extract on knee joint: a double-blind, randomized and parallel study - Investigation of the effects of 8-week continuous ingestion of plant tuber extract on knee joint: a double-blind, randomized and parallel study

IMEQRD Co., Ltd0 个研究点目标入组 40 人开始时间: 2019年7月31日最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40years-old 至 75years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Currently in treatment with medical products. 2) Currently under exercise and diet treatment. 3) Currently visiting hospital for treatment of knee pain. 4) More than 2 of KL (Kellgren-Lawrence) classification grade. 5) Diagnosed with hyperuricemia and the possible occurrence of an attack of gout. 6) Diagnosed with severe disorders such as diabetes, a circulatory disease, a hepatic disease, a renal disease and a cardiac disease, or previous history. 7) Positive at rheumatoid factor, or may cause pain from rheumatism. 8) Undergone or need knee surgery. 9) Need for pharmacological articular treatments during the study. 10) Undergone a hyaluronic acid injection within two weeks before the selection or a steroid injection within three months before the selection. 11) Diagnosed with bone or joint-related diseases such as a fracture and a sprain within the past three months. 12) Regular intake of health food that contains hyaluronic acid, glucosamine, chondroitin sulfuric acid, quercetin glycoside, vitamin D, or an amino-acid drug, or have the intention of consuming the health food during the study. 13) Regular intake of a medical products with an influence on the evaluation of the study (particularly, a medical products that contains glucosamine, chondroitin sulfuric acid, vitamin D or an amino-acid drug, or a medical products for the treatment of osteoporosis). 14) Excessive alcohol (over 60 g per day) intake. 15) Regular use of a cane. 16) Medical history of drug or food allergy. 17) Having the potential to become pregnant during the study or currently pregnant (including a possibility of being pregnant) or nursing. 18) Currently or history of drug abuse. 19) More than 30 kg / m2 of BMI. 20) Participated in other clinical trials within a month from the date of obtaining consent, or during the study. 21) Matched with exclusion criteria, since submission of an informed consent. 22) Unsuitable for enrollment in the opinion of the principal or sub investigator.

研究者

发起方
IMEQRD Co., Ltd

相似试验